These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37743854)

  • 1. The role of pharmacists in deprescribing benzodiazepines: A scoping review.
    Ashkanani FZ; Rathbone AP; Lindsey L
    Explor Res Clin Soc Pharm; 2023 Dec; 12():100328. PubMed ID: 37743854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacists' contribution to benzodiazepine deprescribing in older outpatients: a systematic review and meta-analysis.
    Melo TAR; Bezerra CO; Fernandes BD; Rotta I; Reis WCT; Aguiar PM
    Int J Clin Pharm; 2023 Oct; 45(5):1037-1049. PubMed ID: 37713028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stakeholders' perspectives and experiences of the pharmacist's role in deprescribing in ambulatory care: A qualitative meta-synthesis.
    Kassis A; Moles R; Carter S
    Res Social Adm Pharm; 2024 Aug; 20(8):697-712. PubMed ID: 38685144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-based pharmacists' role in deprescribing: A systematic review.
    Bužančić I; Kummer I; Držaić M; Ortner Hadžiabdić M
    Br J Clin Pharmacol; 2022 Feb; 88(2):452-463. PubMed ID: 34155673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study.
    Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N
    BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teaching Deprescribing and Combating Polypharmacy in the Pharmacy Curriculum: Educational Recommendations from Thematic Analysis of Focus Groups.
    Scott D; Cernasev A; Barenie RE; Springer SP; Axon DR
    Clin Pract; 2023 Mar; 13(2):442-453. PubMed ID: 36961065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring deprescribing opportunities for community pharmacists using the Behaviour Change Wheel.
    Korenvain C; MacKeigan LD; Dainty KN; Guilcher SJT; McCarthy LM
    Res Social Adm Pharm; 2020 Dec; 16(12):1746-1753. PubMed ID: 32094042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.
    Evrard P; Pétein C; Beuscart JB; Spinewine A
    Implement Sci; 2022 Jul; 17(1):41. PubMed ID: 35804428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review.
    Pollmann AS; Murphy AL; Bergman JC; Gardner DM
    BMC Pharmacol Toxicol; 2015 Jul; 16():19. PubMed ID: 26141716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: A rapid review.
    Niznik JD; Collins BJ; Armistead LT; Larson CK; Kelley CJ; Hughes TD; Sanders KA; Carlson R; Ferreri SP
    Res Social Adm Pharm; 2022 Jun; 18(6):2913-2921. PubMed ID: 34281786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effectiveness of a joint general practitioner-pharmacist intervention on the implementation of benzodiazepine deprescribing in older adults (BESTOPH-MG trial): protocol for a cluster-randomized controlled trial.
    Huon JF; Nizet P; Caillet P; Lecompte H; Victorri-Vigneau C; Fournier JP;
    Front Med (Lausanne); 2023; 10():1228883. PubMed ID: 37711743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.
    Keller MS; Carrascoza-Bolanos J; Breda K; Kim LY; Kennelty KA; Leang DW; Murry LT; Nuckols TK; Schnipper JL; Pevnick JM
    BMJ Open; 2023 Feb; 13(2):e066234. PubMed ID: 36813499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deprescribing interventions in primary health care mapped to the Behaviour Change Wheel: A scoping review.
    Isenor JE; Bai I; Cormier R; Helwig M; Reeve E; Whelan AM; Burgess S; Martin-Misener R; Kennie-Kaulbach N
    Res Social Adm Pharm; 2021 Jul; 17(7):1229-1241. PubMed ID: 32978088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are pharmacists' knowledge and practice the key to promoting deprescribing of potentially inappropriate medication: a missing link between treatment and outcomes.
    El-Dahiyat F; Jairoun AA; Al-Hemyari SS; Shahwan M; Hassan N; Jairoun S; Jaber AAS
    Int J Pharm Pract; 2023 Jun; 31(4):387-395. PubMed ID: 37116892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "I Think Deprescribing as a Whole Is a Gap!": A Qualitative Study of Student Pharmacist Perceptions about Deprescribing.
    Springer SP; Cernasev A; Barenie RE; Axon DR; Scott D
    Geriatrics (Basel); 2022 Jun; 7(3):. PubMed ID: 35735765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians' views on pharmacists' involvement in hospital deprescribing: A qualitative study on proton pump inhibitors.
    Gendre P; Mayol S; Mocquard J; Huon JF
    Basic Clin Pharmacol Toxicol; 2023 Dec; 133(6):718-728. PubMed ID: 37081726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stakeholder perspectives on pharmacist involvement in a memory clinic to review patients' medication management and assist with deprescribing.
    Cross AJ; Le VJ; George J; Woodward MC; Elliott RA
    Res Social Adm Pharm; 2020 May; 16(5):681-688. PubMed ID: 31405811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community pharmacists' role in benzodiazepine supply in Ireland: a questionnaire of pharmacists' views and experiences.
    Cadogan CA; Ryder SA
    Int J Pharm Pract; 2015 Dec; 23(6):415-22. PubMed ID: 25756294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.